BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 15972871)

  • 1. Sudden death after myocardial infarction--who needs prophylaxis, and when?
    Buxton AE
    N Engl J Med; 2005 Jun; 352(25):2638-40. PubMed ID: 15972871
    [No Abstract]   [Full Text] [Related]  

  • 2. Sudden death in patients with myocardial infarction.
    Khera A; Levine BD
    N Engl J Med; 2005 Sep; 353(12):1294-7; author reply 1294-7. PubMed ID: 16180270
    [No Abstract]   [Full Text] [Related]  

  • 3. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both.
    Solomon SD; Zelenkofske S; McMurray JJ; Finn PV; Velazquez E; Ertl G; Harsanyi A; Rouleau JL; Maggioni A; Kober L; White H; Van de Werf F; Pieper K; Califf RM; Pfeffer MA;
    N Engl J Med; 2005 Jun; 352(25):2581-8. PubMed ID: 15972864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sudden death in patients with myocardial infarction.
    Zijlstra F; van der Horst IC
    N Engl J Med; 2005 Sep; 353(12):1294-7; author reply 1294-7. PubMed ID: 16180271
    [No Abstract]   [Full Text] [Related]  

  • 5. Sudden death in patients with myocardial infarction.
    Jacobs AG
    N Engl J Med; 2005 Sep; 353(12):1294-7; author reply 1294-7. PubMed ID: 16180269
    [No Abstract]   [Full Text] [Related]  

  • 6. Pathogenesis of sudden unexpected death in a clinical trial of patients with myocardial infarction and left ventricular dysfunction, heart failure, or both.
    Pouleur AC; Barkoudah E; Uno H; Skali H; Finn PV; Zelenkofske SL; Belenkov YN; Mareev V; Velazquez EJ; Rouleau JL; Maggioni AP; Køber L; Califf RM; McMurray JJ; Pfeffer MA; Solomon SD;
    Circulation; 2010 Aug; 122(6):597-602. PubMed ID: 20660803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation of body mass index to sudden cardiac death and the benefit of implantable cardioverter-defibrillator in patients with left ventricular dysfunction after healing of myocardial infarction.
    Choy B; Hansen E; Moss AJ; McNitt S; Zareba W; Goldenberg I;
    Am J Cardiol; 2010 Mar; 105(5):581-6. PubMed ID: 20185000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary prevention: a necessity after myocardial infarction with left ventricular dysfunction.
    Valk S; Jordaens L
    Europace; 2009 Apr; 11(4):407-8. PubMed ID: 19279027
    [No Abstract]   [Full Text] [Related]  

  • 9. Major adverse cardiac event predictors in survivors of myocardial infarction with asymptomatic left ventricular dysfunction or chronic heart failure.
    Kuch M; Janiszewski M; Mamcarz A; Cudnoch-Jedrzejewska A; Dłuzniewski M
    Med Sci Monit; 2009 Jun; 15(6):PH40-8. PubMed ID: 19478711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of sudden cardiac death in myocardial infarction survivors: insights from the randomized trials of implantable cardioverter-defibrillators.
    Bunch TJ; Hohnloser SH; Gersh BJ
    Circulation; 2007 May; 115(18):2451-7. PubMed ID: 17485594
    [No Abstract]   [Full Text] [Related]  

  • 11. Prophylactic implantable cardioverter-defibrillators after myocardial infarction--not for everyone.
    Gillis AM
    N Engl J Med; 2004 Dec; 351(24):2540-2. PubMed ID: 15590957
    [No Abstract]   [Full Text] [Related]  

  • 12. [Primary prevention of sudden cardiac death].
    Reek S; Geller JC; Klein HU
    Dtsch Med Wochenschr; 2001 Apr; 126(15):435-8. PubMed ID: 11347006
    [No Abstract]   [Full Text] [Related]  

  • 13. Revascularization versus implantable cardioverter-defibrillators to prevent sudden death in patients with severe left ventricular dysfunction.
    Weintraub WS
    Circulation; 2001 Sep; 104(13):1457-8. PubMed ID: 11571235
    [No Abstract]   [Full Text] [Related]  

  • 14. Implantable cardioverter-defibrillator therapy after acute myocardial infarction: the results are not shocking.
    Goldberger JJ; Passman R
    J Am Coll Cardiol; 2009 Nov; 54(22):2001-5. PubMed ID: 19926004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator.
    Roes SD; Borleffs CJ; van der Geest RJ; Westenberg JJ; Marsan NA; Kaandorp TA; Reiber JH; Zeppenfeld K; Lamb HJ; de Roos A; Schalij MJ; Bax JJ
    Circ Cardiovasc Imaging; 2009 May; 2(3):183-90. PubMed ID: 19808591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sudden cardiovascular death following myocardial infarction: the importance of left ventricular systolic dysfunction and congestive heart failure.
    Abildstrom SZ; Ottesen MM; Rask-Madsen C; Andersen PK; Rosthøj S; Torp-Pedersen C; Køber L
    Int J Cardiol; 2005 Sep; 104(2):184-9. PubMed ID: 16168812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heart failure therapy and sudden cardiac death prevention.
    Morgan JM
    Minerva Cardioangiol; 2004 Dec; 52(6):521-4. PubMed ID: 15729212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethical issues with implantable defibrillators.
    Veenhuyzen GD; Simpson CS
    Pacing Clin Electrophysiol; 2005 Feb; 28(2):173-4; author reply 174. PubMed ID: 15679652
    [No Abstract]   [Full Text] [Related]  

  • 19. Ethical issues with implantable defibrillators.
    Brennan FJ
    Pacing Clin Electrophysiol; 2004 Jul; 27(7):897-8. PubMed ID: 15271005
    [No Abstract]   [Full Text] [Related]  

  • 20. [Risk stratification and prevention of sudden death in patients with heart failure].
    Villacastín J; Bover R; Castellano NP; Moreno J; Morales R; García-Espinosa A
    Rev Esp Cardiol; 2004 Aug; 57(8):768-82. PubMed ID: 15282066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.